Scott Moore explores China’s trajectory in the worldwide biotechnology sector. Though America has become the dominant global participant in producing and commercializing biotechnology for decades, China is set to be a number one player in biotechnology and is also investing closely inside the sector. Moore argues that, though the U.S. is probably